These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 1656759)

  • 21. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
    Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
    Caduff RF; Johnston CM; Frank TS
    Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
    Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
    N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
    Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
    Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
    Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
    Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes.
    Yoo J; Robinson RA; Lee JY
    Mod Pathol; 1999 Aug; 12(8):775-80. PubMed ID: 10463479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
    Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
    Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary.
    Alvarez AA; Moore WF; Robboy SJ; Bentley RC; Gumbs C; Futreal PA; Berchuck A
    Gynecol Oncol; 2001 Feb; 80(2):201-6. PubMed ID: 11161860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
    Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
    Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
    Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M
    Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K-ras activation in non-small cell lung cancer in the dog.
    Kraegel SA; Gumerlock PH; Dungworth DL; Oreffo VI; Madewell BR
    Cancer Res; 1992 Sep; 52(17):4724-7. PubMed ID: 1324792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.
    Lin WL; Kuo WH; Chen FL; Lee MY; Ruan A; Tyan YS; Hsu JD; Chiang H; Han CP
    Ann Surg Oncol; 2011 Aug; 18(8):2388-94. PubMed ID: 21347793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.